-
Stay Connected
Get the latest news on exciting speakers, workshops & learning opportunities at ISDE 2021.
Subscribe for Updates
Endoscopic full-thickness resection (EFTR) is changing the management of selected submucosal tumours in the oesophagus and upper gastrointestinal tract. The technique removes a lesion through the mucosa and muscular wall, with deliberate closure of the resulting defect. It can provide a complete specimen when a standard mucosal biopsy is inconclusive or when endoscopic mucosal resection cannot reach the tumour safely.
Interest in EFTR has grown alongside endoscopic submucosal dissection (ESD), submucosal tunnelling endoscopic resection (STER), and newer closure systems. These approaches are especially relevant to lesions arising from the muscularis propria, including small leiomyomas and carefully selected gastrointestinal stromal tumours (GISTs). The aim is to achieve definitive histology while avoiding a thoracic or abdominal operation.
The 17th World Congress for Esophageal Diseases, held virtually from 27–30 September 2021, brought together research and clinical education in this field. Its archived programme remains useful for clinicians reviewing the evidence, technical demonstrations, and multidisciplinary standards that shape advanced oesophageal endoscopy.
Many submucosal tumours have normal-looking overlying mucosa, so routine forceps biopsy may yield little useful tissue. Endoscopic ultrasound helps define the layer of origin, internal echogenicity, borders, and relationship to nearby structures. Cross-sectional imaging may add information about size, nodal disease, or extra-luminal extension.
EFTR offers an intact or near-intact specimen for formal histopathology and immunohistochemistry. This can help distinguish leiomyoma from GIST, schwannoma, granular cell tumour, or less common pathology. Mitotic activity, KIT and DOG1 expression, margins, and depth all influence later surveillance or oncology decisions.
The strongest candidates are usually small, localised lesions with no evidence of invasion or metastasis. A tumour confined to the oesophageal wall may be approached using a submucosal tunnel, allowing the endoscopist to dissect around the lesion before closing the entry point. Lesion size, location, firmness, mobility, and proximity to major vessels all affect feasibility.
A large tumour, suspected high-risk GIST, ulcerated mass, or lesion extending beyond the wall may be better managed through a surgical pathway. The decision should involve an upper gastrointestinal multidisciplinary team, with input from an advanced endoscopist, upper GI surgeon, radiologist, pathologist, and anaesthetist. In Australia, this discussion commonly occurs through tertiary services in Sydney, Melbourne, Brisbane, Perth, or Adelaide when local hospitals do not offer advanced therapeutic endoscopy.
Modern EFTR depends on reliable closure. Through-the-scope clips, over-the-scope clips, endoscopic suturing, and dedicated full-thickness resection devices can seal defects and reduce leakage. In the oesophagus, the confined anatomy and constant movement make closure particularly important, and some cases require a staged or hybrid technique rather than a single standardised method.
STER can be attractive for selected intramural tumours because the mucosal entry site is separated from the resection cavity. It has been used extensively for muscularis propria lesions, particularly in the middle and lower oesophagus. EFTR remains technically demanding, and published studies are often retrospective, single-centre series with relatively small patient numbers. Long-term comparisons with surgery continue to evolve.
Potential complications include bleeding, perforation, mediastinal contamination, infection, chest pain, fever, aspiration, and delayed stricture formation. A patient may require admission, intravenous antibiotics, contrast imaging, and a period without oral intake if a substantial wall defect has been created. Early recognition of fever, tachycardia, worsening chest pain, or swallowing difficulty is essential.
Careful follow-up verifies healing and confirms that pathology matches the initial imaging assessment. Surveillance endoscopy or imaging may be recommended for GIST or an incompletely excised lesion. Australian patients should also receive clear advice about where to present after discharge, particularly those travelling from regional New South Wales, Queensland, or Western Australia to a metropolitan centre.
Patients considering a procedure should receive a written explanation of alternatives, including surveillance, ESD, STER, laparoscopic or open surgery, and the possibility that an endoscopic procedure may need to be abandoned or converted to another treatment.
Advanced endoscopic resection should be concentrated in units with appropriate equipment, anaesthetic support, radiology access, surgical backup, and pathology expertise. Local market realities matter: device availability, public hospital procurement, private insurance arrangements, and travel costs can influence where treatment is delivered. Medicare coverage and private billing should be clarified before admission rather than assumed.
Useful priorities for a safe programme include:
Education remains important because the learning curve is substantial. Australian clinicians can use international congress resources, peer-reviewed case series, simulation, proctoring, and observerships to build capability. The archived ISDE platform also provides congress registration information and related educational context, although the 2021 event itself has finished.
EFTR is best viewed as a specialised option rather than a universal replacement for surgery. Its value lies in matching a carefully characterised lesion with an experienced team, an appropriate resection route, dependable closure, and a clear rescue plan. For a current case, the concrete next step is to obtain endoscopic ultrasound and imaging, then take the findings to an upper gastrointestinal multidisciplinary meeting before choosing surveillance, endoscopic resection, or surgery.